{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:03:44Z","timestamp":1784891024346,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20242BAB20351"],"award-info":[{"award-number":["20242BAB20351"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Natural Science Foundation of Jiangxi Province","doi-asserted-by":"publisher","award":["20202ACBL206009"],"award-info":[{"award-number":["20202ACBL206009"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860099"],"award-info":[{"award-number":["81860099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10552-026-02193-6","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T15:44:56Z","timestamp":1783525496000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Epidemiological landscape and clinical heterogeneity of primary pancreatic lymphoma: a population-based study"],"prefix":"10.1007","volume":"37","author":[{"given":"Le","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghua","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"2193_CR1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/jso.2930050410","volume":"5","author":"SM Baylor","year":"1973","unstructured":"Baylor SM, Berg JW (1973) Cross-classification and survival characteristics of 5,000 cases of cancer of the pancreas. J Surg Oncol 5:335\u2013358","journal-title":"J Surg Oncol"},{"key":"2193_CR2","doi-asserted-by":"crossref","unstructured":"Zucca E, Roggero E, Bertoni F, Cavalli F (1997) Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol; 8: 727\u2013737.","DOI":"10.1023\/A:1008282818705"},{"key":"2193_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/bjs.18004921319","volume":"49","author":"IM Dawson","year":"1961","unstructured":"Dawson IM, Cornes JS, Morson BC (1961) Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg 49:80\u201389","journal-title":"Br J Surg"},{"key":"2193_CR4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/00006676-199409000-00019","volume":"9","author":"KE Behrns","year":"1994","unstructured":"Behrns KE, Sarr MG, Strickler JG (1994) Pancreatic lymphoma: is it a surgical disease? Pancreas 9:662\u2013667","journal-title":"Pancreas"},{"key":"2193_CR5","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.annpat.2011.08.001","volume":"31","author":"JF Flejou","year":"2011","unstructured":"Flejou JF (2011) WHO classification of digestive tumors: the fourth edition. Ann Pathol 31:S27-31","journal-title":"Ann Pathol"},{"key":"2193_CR6","first-page":"834","volume":"7","author":"RE Alexander","year":"2011","unstructured":"Alexander RE, Nakeeb A, Sandrasegaran K, Robertson MJ, An C, Al-Haddad MA et al (2011) Primary pancreatic follicle center-derived lymphoma masquerading as carcinoma. Gastroenterol Hepatol (N Y) 7:834\u2013838","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"2193_CR7","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1245\/s10434-014-4176-6","volume":"22","author":"E Sadot","year":"2015","unstructured":"Sadot E, Yahalom J, Do RK, Teruya-Feldstein J, Allen PJ, Gonen M et al (2015) Clinical features and outcome of primary pancreatic lymphoma. Ann Surg Oncol 22:1176\u20131184","journal-title":"Ann Surg Oncol"},{"key":"2193_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/JBM.S273095","volume":"12","author":"D Facchinelli","year":"2021","unstructured":"Facchinelli D, Boninsegna E, Visco C, Tecchio C (2021) Primary pancreatic lymphoma: recommendations for diagnosis and management. J Blood Med 12:257\u2013267","journal-title":"J Blood Med"},{"key":"2193_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.21037\/jgo.2017.06.03","volume":"8","author":"N Rad","year":"2017","unstructured":"Rad N, Khafaf A, Mohammad Alizadeh AH (2017) Primary pancreatic lymphoma: what we need to know. J Gastrointest Oncol 8:749\u2013757","journal-title":"J Gastrointest Oncol"},{"key":"2193_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1148\/rg.2018170201","volume":"38","author":"MA Manning","year":"2018","unstructured":"Manning MA, Paal EE, Srivastava A, Mortele KJ (2018) Nonepithelial neoplasms of the pancreas, Part 2: malignant tumors and tumors of uncertain malignant potential from the radiologic pathology archives. Radiographics 38:1047\u20131072","journal-title":"Radiographics"},{"key":"2193_CR11","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/COC.0000000000000544","volume":"42","author":"D Mukhija","year":"2019","unstructured":"Mukhija D, Nagpal SJS, Sohal DPS (2019) Epidemiology, tumor characteristics, and survival in patients with primary pancreatic lymphoma: a large population-based study using the SEER database. Am J Clin Oncol 42:454\u2013458","journal-title":"Am J Clin Oncol"},{"key":"2193_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2021.759162","volume":"8","author":"Y Gu","year":"2021","unstructured":"Gu Y, Deng H, Wang D, Li Y (2021) Metastasis pattern and survival analysis in primary small bowel adenocarcinoma: a SEER-based study. Front Surg 8:759162","journal-title":"Front Surg"},{"key":"2193_CR13","doi-asserted-by":"publisher","first-page":"19348","DOI":"10.1038\/s41598-021-98960-3","volume":"11","author":"J Li","year":"2021","unstructured":"Li J, Huang W, Chen J, Li Z, Liu B, Wang P et al (2021) Nomograms for predicting the overall survival of patients with cerebellar glioma: an analysis of the surveillance epidemiology and end results (SEER) database. Sci Rep 11:19348","journal-title":"Sci Rep"},{"key":"2193_CR14","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2021.3425","author":"DB Taylor","year":"2021","unstructured":"Taylor DB, Osazuwa-Peters OL, Okafor SI, Boakye EA, Kuziez D, Perera et al (2021) Differential outcomes among survivors of head and neck cancer belonging to racial and ethnic minority groups. JAMA Otolaryngol\u2013Head & Neck Surg. https:\/\/doi.org\/10.1001\/jamaoto.2021.3425","journal-title":"JAMA Otolaryngol\u2013Head & Neck Surg"},{"key":"2193_CR15","doi-asserted-by":"publisher","first-page":"e995","DOI":"10.1016\/j.clgc.2019.05.008","volume":"17","author":"JM Sung","year":"2019","unstructured":"Sung JM, Martin JW, Jefferson FA, Sidhom DA, Piranviseh K, Huang M et al (2019) Racial and socioeconomic disparities in bladder cancer survival: analysis of the California cancer registry. Clin Genitourin Cancer 17:e995\u2013e1002","journal-title":"Clin Genitourin Cancer"},{"key":"2193_CR16","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.jtho.2020.06.018","volume":"15","author":"J Lee","year":"2020","unstructured":"Lee J, Choi Y, Han J, Park S, Jung HA, Su JM et al (2020) Osimertinib improves overall survival in patients with EGFR-mutated NSCLC with leptomeningeal metastases regardless of T790M mutational status. J Thorac Oncol 15:1758\u20131766","journal-title":"J Thorac Oncol"},{"key":"2193_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100931","volume":"14","author":"MJ Qiu","year":"2021","unstructured":"Qiu MJ, Fang XF, Huang ZZ, Li QT, Wang MM, Jiang X et al (2021) Prognosis of primary hepatic lymphoma: a US population-based analysis. Transl Oncol 14:100931","journal-title":"Transl Oncol"},{"key":"2193_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.698866","volume":"11","author":"C Zhang","year":"2021","unstructured":"Zhang C, Zhao S, Wang X (2021) A prognostic nomogram for T3N0 rectal cancer after total mesorectal excision to help select patients for adjuvant therapy. Front Oncol 11:698866","journal-title":"Front Oncol"},{"key":"2193_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#","volume":"29","author":"C Freeman","year":"1972","unstructured":"Freeman C, Berg JW, Cutler SJ (1972) Occurrence and prognosis of extranodal lymphomas. Cancer 29:252\u2013260","journal-title":"Cancer"},{"key":"2193_CR20","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","volume":"30","author":"A Miranda-Filho","year":"2019","unstructured":"Miranda-Filho A, Pineros M, Znaor A, Marcos-Gragera R, Steliarova-Foucher E, Bray F (2019) Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control 30:489\u2013499","journal-title":"Cancer Causes Control"},{"key":"2193_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243561","volume":"15","author":"D Chekol","year":"2020","unstructured":"Chekol D, Bedimo M, Mulugeta Y, Bantie GM (2020) Determinants of non-Hodgkin\u2019s lymphoma at Felegehiwot specialized hospital, North West Ethiopia: a case-control study. PLoS ONE 15:e0243561","journal-title":"PLoS ONE"},{"key":"2193_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/bjh.12753","volume":"165","author":"PJ Hosein","year":"2014","unstructured":"Hosein PJ, Maragulia JC, Salzberg MP, Press OW, Habermann TM, Vose JM et al (2014) A multicentre study of primary breast diffuse large B-cell lymphoma in the rituximab era. Br J Haematol 165:358\u2013363","journal-title":"Br J Haematol"},{"key":"2193_CR23","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/1568009617666170109151128","volume":"17","author":"D Shanehbandi","year":"2017","unstructured":"Shanehbandi D, Majidi J, Kazemi T, Baradaran B, Aghebati-Maleki L (2017) CD20-based immunotherapy of B-cell derived hematologic malignancies. Curr Cancer Drug Targets 17:423\u2013444","journal-title":"Curr Cancer Drug Targets"},{"key":"2193_CR24","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41598-021-82841-w","volume":"11","author":"C Luo","year":"2021","unstructured":"Luo C, Wu G, Huang X, Ma Y, Zhang Y, Song Q et al (2021) Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20(+) B-cell non-Hodgkin lymphomas: a systematic review and meta-analysis. Sci Rep 11:3255","journal-title":"Sci Rep"},{"key":"2193_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/COC.0b013e3182354bbb","volume":"36","author":"MV Mishra","year":"2013","unstructured":"Mishra MV, Keith SW, Shen X, Bar AdV, Champ CE, Biswas T (2013) Primary pancreatic lymphoma: a population-based analysis using the SEER program. Am J Clin Oncol 36:38\u201343","journal-title":"Am J Clin Oncol"},{"issue":"14","key":"2193_CR26","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.3390\/cancers13143479","volume":"13","author":"A Morales-Martinez","year":"2021","unstructured":"Morales-Martinez A, Lozano-Sanchez F, Duran-Pe\u00f1a A, Hoang-Xuan K, Houillier C (2021) Primary central nervous system lymphoma in elderly patients: management and perspectives. Cancers 13(14):3479","journal-title":"Cancers"},{"key":"2193_CR27","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.3332\/ecancer.2021.1242","volume":"15","author":"C Sarker","year":"2021","unstructured":"Sarker C, Radhakrishnan VS, Mandal P, Kumar J, Bhave S, Achari R et al (2021) Outcomes of diffuse large B-cell lymphoma in elderly patients-real-world experience from a middle-income country setting. Ecancermedicalscience 15:1242","journal-title":"Ecancermedicalscience"},{"key":"2193_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1186\/s12885-021-08326-1","volume":"21","author":"X Yang","year":"2021","unstructured":"Yang X, Khoo LP, Chang EWY, Yang VS, Poon E, Somasundaram N et al (2021) Treatment patterns and outcomes of older patients with mantle cell lymphoma in an Asian population. BMC Cancer 21:566","journal-title":"BMC Cancer"},{"key":"2193_CR29","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/leu.2011.68","volume":"25","author":"K Yakimchuk","year":"2011","unstructured":"Yakimchuk K, Iravani M, Hasni MS, Rhonnstad P, Nilsson S, Jondal M et al (2011) Effect of ligand-activated estrogen receptor beta on lymphoma growth in vitro and in vivo. Leukemia 25:1103\u20131110","journal-title":"Leukemia"},{"key":"2193_CR30","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1182\/blood-2013-07-517292","volume":"123","author":"K Yakimchuk","year":"2014","unstructured":"Yakimchuk K, Hasni MS, Guan J, Chao MP, Sander B, Okret S (2014) Inhibition of lymphoma vascularization and dissemination by estrogen receptor beta agonists. Blood 123:2054\u20132061","journal-title":"Blood"},{"key":"2193_CR31","doi-asserted-by":"publisher","first-page":"8522","DOI":"10.18632\/oncotarget.14338","volume":"8","author":"M Pierdominici","year":"2017","unstructured":"Pierdominici M, Maselli A, Locatelli SL, Ciarlo L, Careddu G, Patrizio M et al (2017) Estrogen receptor beta ligation inhibits Hodgkin lymphoma growth by inducing autophagy. Oncotarget 8:8522\u20138535","journal-title":"Oncotarget"},{"key":"2193_CR32","first-page":"1860","volume":"31","author":"PP Carbone","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M (1971) Report of the committee on Hodgkin\u2019s disease staging classification. Cancer Res 31:1860\u20131861","journal-title":"Cancer Res"},{"key":"2193_CR33","unstructured":"Smithers DW.(1971) Summary of papers delivered at the conference on staging in Hodgkin's disease (Ann Arbor). Cancer Res; 31: 1869\u20131870"},{"key":"2193_CR34","first-page":"368","volume":"55","author":"JO Armitage","year":"2005","unstructured":"Armitage JO (2005) Staging non-Hodgkin lymphoma. CA Cancer J Clin 55:368\u2013376","journal-title":"CA Cancer J Clin"},{"key":"2193_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4103\/0971-5851.203500","volume":"38","author":"DC Doval","year":"2017","unstructured":"Doval DC, Bhurani D, Nair R, Gujral S, Malhotra P, Ramanan G et al (2017) Indian council of medical research consensus document for the management of non-Hodgkin\u2019s lymphoma (High Grade). Indian J Med Paediatr Oncol 38:51\u201358","journal-title":"Indian J Med Paediatr Oncol"},{"key":"2193_CR36","volume":"12","author":"A Tikue","year":"2020","unstructured":"Tikue A, Bedanie G, Brandi L, Islam S, Nugent K (2020) Primary pancreatic large B-Cell lymphoma presenting as acute pancreatitis. Cureus 12:e9583","journal-title":"Cureus"},{"key":"2193_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/2040620717738740","volume":"8","author":"TP Wang","year":"2017","unstructured":"Wang TP, Scott JH, Barta SK (2017) The evolving role of targeted biological agents in the management of indolent B-cell lymphomas. Ther Adv Hematol 8:329\u2013344","journal-title":"Ther Adv Hematol"},{"key":"2193_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13045-020-01018-6","volume":"14","author":"M Lumish","year":"2021","unstructured":"Lumish M, Falchi L, Imber BS, Scordo M, von Keudell G, Joffe E (2021) How we treat mature B-cell neoplasms (indolent B-cell lymphomas). J Hematol Oncol 14:5","journal-title":"J Hematol Oncol"},{"key":"2193_CR39","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/dc.24349","volume":"48","author":"O Savari","year":"2020","unstructured":"Savari O, Al-Duwal Z, Wang Z, Ganesan S, Danan-Rayes R, Ayub S (2020) Pancreatic lymphoma: a cytologic diagnosis challenge. Diagn Cytopathol 48:350\u2013355","journal-title":"Diagn Cytopathol"},{"key":"2193_CR40","volume":"11","author":"Y Zafar","year":"2019","unstructured":"Zafar Y, Kaur A, Banno F, Anuj S (2019) Primary pancreatic lymphoma: an uncommon presentation in the pancreatic tail. Cureus 11:e5479","journal-title":"Cureus"},{"key":"2193_CR41","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1517\/14740330902750114","volume":"8","author":"MC Winter","year":"2009","unstructured":"Winter MC, Hancock BW (2009) Ten years of rituximab in NHL. Expert Opin Drug Saf 8:223\u2013235","journal-title":"Expert Opin Drug Saf"},{"key":"2193_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.3389\/fonc.2020.00750","volume":"10","author":"SL Zhang","year":"2020","unstructured":"Zhang SL, Chen C, Rao QW, Guo Z, Wang X, Wang ZM et al (2020) Incidence, prognostic factors and survival outcome in patients with primary hepatic lymphoma. Front Oncol 10:750","journal-title":"Front Oncol"},{"key":"2193_CR43","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/00000658-198901000-00003","volume":"209","author":"TH Webb","year":"1989","unstructured":"Webb TH, Lillemoe KD, Pitt HA, Jones RJ, Cameron JL (1989) Pancreatic lymphoma. Is surgery mandatory for diagnosis or treatment? Ann Surg 209:25\u201330","journal-title":"Ann Surg"},{"key":"2193_CR44","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP (2015) Nomograms in oncology: more than meets the eye. Lancet Oncol 16:e173-180","journal-title":"Lancet Oncol"},{"key":"2193_CR45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/j.seminhematol.2016.05.003","volume":"53","author":"PJ Brockelmann","year":"2016","unstructured":"Brockelmann PJ, Angelopoulou MK, Vassilakopoulos TP (2016) Prognostic factors in Hodgkin lymphoma. Semin Hematol 53:155\u2013164","journal-title":"Semin Hematol"},{"key":"2193_CR46","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.blre.2018.03.005","volume":"32","author":"JC Wight","year":"2018","unstructured":"Wight JC, Chong G, Grigg AP, Hawkes EA (2018) Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. Blood Rev 32:400\u2013415","journal-title":"Blood Rev"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02193-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10552-026-02193-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-026-02193-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:57:23Z","timestamp":1784890643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10552-026-02193-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2193"],"URL":"https:\/\/doi.org\/10.1007\/s10552-026-02193-6","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the procedures followed were in accordance with the Hel-sinki Declaration of the World Medical Association (as revised in 2013). The data released by the SEER database was publicly available and therefore did not require informed patient consent.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"124"}}